| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 232 | $32.85 | $7,621.20 | View Details Filing |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 1,547 | $32.11 | $49,674.17 | View Details Filing |
| Feb 3, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 6,956 | $32.12 | $223,426.72 | View Details Filing |
| Jan 31, 2026 | Travere Therapeutics, Inc. (TVTX) | A | 75,000 | $0.00 | $0.00 | View Details Filing |
| Jan 31, 2026 | Travere Therapeutics, Inc. (TVTX) | A | 28,130 | $0.00 | $0.00 | View Details Filing |
| Jan 6, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 445 | $37.75 | $16,798.75 | View Details Filing |
| Jan 5, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 2,031 | $40.18 | $81,605.58 | View Details Filing |
| Dec 24, 2025 | Travere Therapeutics, Inc. (TVTX) | M | 15,000 | $8.93 | $133,950.00 | View Details Filing |
| Dec 24, 2025 | Travere Therapeutics, Inc. (TVTX) | M | 15,000 | $0.00 | $0.00 | View Details Filing |
| Dec 24, 2025 | Travere Therapeutics, Inc. (TVTX) | S | 15,000 | $42.00 | $630,004.50 | View Details Filing |